When molecular biology methods failed her, Sangeeta Bhatia turned to engineering and microfabrication to build a liver from scratch.
When molecular biology methods failed her, Sangeeta Bhatia turned to engineering and microfabrication to build a liver from scratch.
A University of Alberta researcher refuses to accept a prestigious scientific award because he thought two of his collaborators should have also been honored.
The NIH will decide what to do with its research chimpanzees by the end of this month.
A human trial of a hepatitis C treatment is shut down after one of the participants died.
The animal rights organization purchases shares of a research facility in a bid to end chimpanzee testing at the facility.
A list of this year’s newsworthy successes—and failures—in drug development
Page 1 of 1